Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176038 | SCV000227625 | pathogenic | not provided | 2015-02-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000176038 | SCV001401960 | pathogenic | not provided | 2024-10-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp778Leufs*42) in the PDE6A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PDE6A are known to be pathogenic (PMID: 7493036, 22128245, 23847139). This variant is present in population databases (rs754012367, gnomAD 0.005%). This premature translational stop signal has been observed in individual(s) with retinitis pigmentosa (PMID: 30718709). ClinVar contains an entry for this variant (Variation ID: 195462). For these reasons, this variant has been classified as Pathogenic. |
Institute of Medical Genetics and Applied Genomics, |
RCV000176038 | SCV001447243 | likely pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Ocular Genomics Institute, |
RCV001376193 | SCV001573245 | pathogenic | Retinitis pigmentosa 43 | 2021-04-08 | criteria provided, single submitter | research | The PDE6A c.2332_2335del variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PVS1, PM2, PP3. Based on this evidence we have classified this variant as Pathogenic. |
MGZ Medical Genetics Center | RCV001376193 | SCV002579893 | likely pathogenic | Retinitis pigmentosa 43 | 2022-05-23 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004816276 | SCV005070338 | pathogenic | Retinal dystrophy | 2015-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001376193 | SCV005670653 | pathogenic | Retinitis pigmentosa 43 | 2024-04-25 | criteria provided, single submitter | clinical testing | |
Department of Clinical Genetics, |
RCV000787640 | SCV000926625 | pathogenic | Retinitis pigmentosa | 2018-04-01 | no assertion criteria provided | research |